title: [Bone mineral density and biological markers of bone repair in patients with adrenal incidentaloma: effect of subclinical hypercortisolism].
abstract: OBJECTIVE
  Some adrenal incidentalomas produce cortisol in mild excess ('subclinical' Cushing's adenomas) and can potentially induce osteopenia. Their diagnosis is usually based on exclusive tumour uptake on adrenal scintigraphy using 131I-6 beta-methyl-iodo-19-norcholesterol and on inadequate cortisol response to dexamethasone (DXM) suppression tests. The aims of the present study were to evaluate bone mineral density (BMD) and metabolic markers of bone turnover in patients with incidentalomas and to test the effect of mild hypercortisolism on bone parameters.
  
  
  METHODS
  Thirty-five patients (13 men, 22 postmenopausal women, 49-76 years) with unilateral incidentaloma were studied. BMD was measured by dual X-ray absorptiometry. Two biochemical markers of bone formation, serum osteocalcin (BGP) and bone alkaline phosphatase (bALP), and two markers of bone resorption, urinary free deoxypyridinoline (D-Pyr) and urinary carboxy-telopeptide of bone type 1 collagen (CTX), were measured by radioimmunoassay. D-Pyr and CTX were corrected for creatinine excretion.
  
  
  RESULTS
  Median values of lumbar and femoral T-score were -1.125 and -0.920, respectively, whereas corresponding Z-score values where normal (0.105 and 0.120, respectively). Thirty-nine percent of patients had low serum BGP values and 3% had low bALP values; 16% showed elevated D-Pyr/creatinine values and 23% increased CTX/creatinine values. Patients both with suppression of the contralateral adrenal on scintigraphy and with an inadequate cortisol response to 1 mg DXM (> 50 nmol/L) (n = 14) presented a lower femoral T-score (P < 0.02) and, to a lesser extent, a lower femoral Z-score (P = 0.11) than other patients (n = 21). The proportion of increased values of CTX/creatinine (42% versus 11%, P = 0.08) also tended to be higher in the first than in the second group of patients. These two groups of patients were similar in terms of age, but tumour size was larger (P < 0.04) and plasma ACTH value was lower (P < 0.02) in patients with scintigraphic and endocrine abnormalities.
  
  
  CONCLUSIONS
  Subclinical hypercortisolism defined on the basis of scintigraphic and hormonal criteria seems to contribute to bone loss in patients with adrenal incidentaloma. As other possible side effects of mild hypercortisolism, these findings have to be taken into account in the therapeutic management of these patients.
authors.affiliation: Service de médecine nucléaire, centre François-Baclesse, route de Lion-sur-Mer, 14076 Caen, France. s.bardet@baclesse.fr
authors.forename: S
authors.initials: S
authors.lastname: Bardet
authors.forename: V
authors.initials: V
authors.lastname: Rohmer
authors.forename: F
authors.initials: F
authors.lastname: Boux de Casson
authors.forename: C
authors.initials: C
authors.lastname: Coffin
authors.forename: N
authors.initials: N
authors.lastname: Ronci
authors.forename: J P
authors.initials: JP
authors.lastname: Sabatier
authors.forename: P
authors.initials: P
authors.lastname: Lecomte
authors.forename: M
authors.initials: M
authors.lastname: Audran
authors.forename: M
authors.initials: M
authors.lastname: Henry-Amar
authors.forename: A
authors.initials: A
authors.lastname: Tabarin
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000150:complications* / Q000000981:diagnostic imaging / Q000473:pathology; D014408:Biomarkers, Tumor / Q000032:analysis*; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000209:etiology*; D001861:Bone Regeneration; D001862:Bone Resorption; D003907:Dexamethasone; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging
chemical_list: D014408:Biomarkers, Tumor; D005938:Glucocorticoids; D003907:Dexamethasone; D006854:Hydrocortisone